29 Apr 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250429747360/en/Shorla-Oncology-Announces-FDA-Approval-of-TEPYLUTE-100mg-First-and-Only-Ready-to-Dilute-Multi-Dose-Vial-of-Thiotepa-to-Treat-Breast-and-Ovarian-Cancer-and-Commercial-Launch-of-TEPYLUTE-15mg-and-100mg-Vials-in-the-U.S.
16 Feb 2023
// EMA
https://www.ema.europa.eu/en/documents/overview/thiotepa-riemser-epar-medicine-overview_en.pdf
29 Jul 2022
// BUSINESSWIRE
03 Jan 2022
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214222
11 May 2020
// HEALTH CANADA
https://www.pharmacompass.com/pdf/news/health-canada-issues-recall-of-methapharm-incs-tepadina-1589269138.pdf
06 Mar 2020
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213049